ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 877.00
+13.00 (1.50%)
At close: Jun 22, 2026
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 51.22 billion as of June 18, 2026. Its market cap has decreased by -76.19% in one year.
Market Cap
51.22B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
877.00
Market Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 51.22B, an increase of 64.17%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 51.22B | -28.12% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 115.16B |
| Vaxcell-Bio Therapeutics | 106.63B |
| Amicogen | 106.60B |
| ENCell | 91.43B |
| iNtRON Biotechnology | 84.09B |
| Prestige BioPharma | 79.21B |
| CG Invites | 79.20B |
| GeneOne Life Science | 62.93B |